RENAL HISTOLOGY AND INTERSTITIAL MORPHOMETRY IN NEPHROTIC PATIENTS TREATED WITH CYCLOSPORINE

被引:0
|
作者
POVEDA, R
CARRERA, M
MORESO, F
CARRERAS, L
GONZALEZ, MT
ALSINA, J
机构
来源
NEFROLOGIA | 1995年 / 15卷 / 03期
关键词
NEPHROTIC SYNDROME; CYCLOSPORINE; RENAL MORPHOMETRY;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Renal biopsies were performed in six adult patient with steroid-resistant or steroid-dependent idiopathic nephrotic syndrome after low-dose CsA therapy. Their histologic diagnoses were MCD (3), Mesangial proliferative GN (1) and FSGS (2). CsA therapy was started at 3 mg/kg/day. Prednisone at 10 mg/kg/day was also given. Remission after therapy was noted in all but one (FSGS/steroid resistant) patient. Mean CsA dose ranged from 3 to 4 mg/kg/day and blood CsA levels from 56 to 110 ng/ml. Therapy was maintained for 12-15 months in CsA responders and for three months in the case of CsA resistance. GFR (Clearance of 51 Cr EDTA) remained within normal limits. Renal biopsies were performed prior to the start of CsA treatment and repeated in the days before the end of therapy. Using semiquantitative methods (Score 1+ to 4+), slight (1+) glomerular and tubulointerstitial sclerotic changes were disclosed only in the two cases with previous steroid-resistance. No vascular changes were observed. Morphometrical analysis of the interstitial surface (IS) was performed by point-counting methods. A decrease of IS during therapy was observed in two patients wich was associated with a good subsequent clinical course: Sustained remission of nephrotic syndrome after stopping CsA (Follow-up 34 months). On the contrary, increased IS during therapy was associated with early relapse after discontinuation of CsA (3 cases) or CsA resistance (1 case).
引用
收藏
页码:252 / 257
页数:6
相关论文
共 50 条
  • [21] CYCLOSPORINE INHIBITS RENAL URIC-ACID TRANSPORT IN RENAL-TRANSPLANTS NOT IN CHILDREN TREATED FOR NEPHROTIC SYNDROME
    STEIDEL, K
    BRANDIS, M
    KRAMER, M
    LEITITIS, JU
    ZIMMERHACKL, LB
    RENAL FAILURE, 1990, 12 (03) : 193 - 198
  • [22] RENAL HISTOPATHOLOGIC ALTERATIONS IN PATIENTS TREATED WITH CYCLOSPORINE FOR UVEITIS
    PALESTINE, AG
    AUSTIN, HA
    BALOW, JE
    ANTONOVYCH, TT
    SABNIS, SG
    PREUSS, HG
    NUSSENBLATT, RB
    NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (20): : 1293 - 1298
  • [23] The effects of diltiazem in renal transplantation patients treated with cyclosporine A
    Xue, Wujun
    Song, Yong
    Tian, Puxun
    Ding, Xiaoming
    Pan, Xiaoming
    Yan, Hang
    Hou, Jun
    Feng, Xinshun
    Xiang, Heli
    Tian, Xiaohui
    JOURNAL OF BIOMEDICAL RESEARCH, 2010, 24 (04): : 317 - 323
  • [24] Effects of isradipine on renal hemodynamics in renal transplant patients treated with cyclosporine
    Ahmed, K
    Michael, B
    Burke, JF
    CLINICAL NEPHROLOGY, 1997, 48 (05) : 307 - 310
  • [25] INFLUENCE OF NIFEDIPINE ON INTERSTITIAL FIBROSIS IN RENAL-TRANSPLANT ALLOGRAFTS TREATED WITH CYCLOSPORINE-A
    MCCULLOCH, TA
    HARPER, SJ
    DONNELLY, PK
    MOORHOUSE, J
    BELL, PRF
    WALLS, J
    FEEHALLY, J
    FURNESS, PN
    JOURNAL OF CLINICAL PATHOLOGY, 1994, 47 (09) : 839 - 842
  • [26] Intravenous cyclosporine A for patients with nephrotic syndrome
    Proesmans, W
    De Rooster, A
    Van Dyck, M
    PEDIATRIC NEPHROLOGY, 2001, 16 (02) : 196 - 197
  • [27] RENAL HISTOLOGY IN SAUDI POPULATION WITH OVERT NEPHROTIC SYNDROME
    ALKHADER, AA
    ALSULAIMAN, M
    DHAR, JM
    ANNALS OF SAUDI MEDICINE, 1990, 10 (05) : 581 - 582
  • [28] HEMOLYTIC UREMIC SYNDROME IN RENAL ALLOGRAFTED PATIENTS TREATED WITH CYCLOSPORINE
    GIROUX, L
    SMEESTERS, C
    CORMAN, J
    PAQUIN, F
    ALLAIRE, G
    STLOUIS, G
    DALOZE, P
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1987, 65 (06) : 1125 - 1131
  • [29] INFECTIONS IN RENAL-TRANSPLANT PATIENTS TREATED WITH CYCLOSPORINE OR AZATHIOPRINE
    VANDORP, WT
    KOOTTE, AMM
    VANGEMERT, GW
    VANES, LA
    PAUL, LC
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1989, 21 (01) : 75 - 80
  • [30] Cyclosporine A for the treatment of refractory nephrotic syndrome with renal dysfunction
    Gao, Xiang
    Ma, Yiyi
    Sun, Lijun
    Chen, Dongping
    Mei, Changlin
    Xu, Chenggang
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2014, 7 (02) : 447 - 450